Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The osteoarthritis therapeutics market is expected to grow from USD 6.8 billion in 2019 to reach... Continue Reading →